Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

366 evidences · page 15 / 15

64 per_1000_person_yearsThe incidence of hypertension was 64 per 1000 person years of observation among individuals with sickle cell anaemia aged ≥15 years enrolled at Muhimbili National Hospital, Tanzania from 2004 to 2014.

Tanzaniedrépanocytoseobservé 2004-2014publié 2017British journal of haematologyeurope_pmcdocument de 3 observations

3,8 %A Tanzanian study approximated hospital mortality for diabetes at 3.8%.

Tanzaniediabète (non précisé)HAL · Unilimdocument de 63 observations

2 %Concurrent HIV was found in 2% of the patients.

Tanzanieinsuffisance cardiaque · VIH/sidapublié 2014Heart (British Cardiac Society)europe_pmcdocument de 13 observations

52,1 %The current national malaria strategy was expected to reduce malaria prevalence between 2016 and 2020 on average by 52.1% if case management were improved.

Tanzaniepaludismeobservé 2016-2020publié 2020PloS oneeurope_pmcdocument de 8 observationsDOI 10.1371/journal.pone.0228469

2,11 RRIn Mbulu district, the relative risk (RR) for under-five mortality was estimated at 2.11.

Tanzaniemortalité infanto-juvénileobservé 2022HAL · Unilimdocument de 238 observations

94 %The proportion of positive responders to CHO-rPvs48/45 was 94% in Tanzania, 90% in Mali, 90% in Burkina Faso, and 40% in Nigeria.

TanzaniepaludismeHAL · Unilimdocument de 25 observations

1,84 SMRIn Buchosa district, the standardized mortality ratio (SMR) for under-five mortality was estimated at 1.84.

Tanzaniemortalité infanto-juvénileobservé 2022HAL · Unilimdocument de 238 observations

90 %Without intervention, 90% of children with sickle cell disease will die in childhood.

Tanzaniedrépanocytosepublié 2017British journal of haematologyeurope_pmcdocument de 4 observations

7 %Acinetobacter species were isolated in 7 of 108 blood cultures from children with sickle-cell anaemia, representing 7%.

Tanzaniedrépanocytosepublié 2009Lancet (London, England)europe_pmcdocument de 12 observations

58,6 %Among enrolled individuals at Muhimbili National Hospital from 2004 to 2013, 58.6% were SCD patients.

Tanzaniedrépanocytoseobservé 2004 to 2013publié 2018BMC hematologyeurope_pmcdocument de 4 observations

0,8 p-valueNo significant changes in whole-body NO production were detected in the base RUSF group, with weight-adjusted systemic NO synthesis of 2.64 ± 1.14 μmol/kg/hr vs 2.53 ± 1.12 μmol/kg/hr (p = 0.80).

Tanzaniedrépanocytosepublié 2018Nitric oxide : biology and chemistryeurope_pmcdocument de 5 observations

41,3 %The prevalence of Plasmodium falciparum parasitemia was 41.3% (13,835 of 33,500) among children without sickle cell disease.

Tanzaniedrépanocytose · paludismepublié 2009Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument de 4 observationsDOI 10.1086/599834

0,94 rate_ratioIn Tanzania, face-to-face consulting rates showed no change with a rate ratio of 0.94 (95% CI 0.61 to 1.67; p=0.99).

Tanzaniemaladies non transmissiblespublié 2023The Lancet. Global healthPubMeddocument de 10 observations

77,5 %Low mean oxygen saturation (77.5%) was recorded from teeth of children with sickle cell disease relative to those with sickle cell trait and HbAA.

Tanzaniedrépanocytosepublié 2022Journal of blood medicineeurope_pmcdocument de 3 observations

17 700 000 inhabitants17.7 million people resided in areas where malaria test positivity rate (TPR) was high (≥ 30) with 90% certainty in the North-West and South-East parts of Tanzania.

Tanzaniepaludismepublié 2023Scientific reportseurope_pmcdocument de 3 observations

1,34 %At enrolment, malaria prevalence was 1.34% in individuals with HbSS genotype.

Tanzaniepaludismepublié 2015PloS oneeurope_pmcdocument de 7 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.